去甲肾上腺素与多巴胺治疗肝肾综合征疗效对比分析

江军; 范平; 陈仕祥; 丁雄芳

去甲肾上腺素与多巴胺治疗肝肾综合征疗效对比分析

1. 解放军第一一三医院感染科
2. 宁波市第一医院药剂科

详细信息

中图分类号: R575.29;R692.5
计量
- 文章访问数: 2280
- HTML全文浏览量: 15
- PDF下载量: 847
- 被引次数: 0
出版历程
- 出版日期: 2009-04-20

摘要

摘要: 目的观察去甲肾上腺素与多巴胺对肝肾综合征的治疗疗效。方法40例肝肾综合征患者随机分成2组,分别用去甲肾上腺素(nonadrenaline,NA)与多巴胺(Dopam ine,DM)进行治疗,观察它们在改善肾功能,增加尿量的疗效。结果NA组治疗后血肌酐、尿素氮均较治疗前明显降低(P<0.05),DM组治疗后日尿量较治疗前明显升高(P<0.05)。结论NA组效果优于DM组,NA能使患者肝肾综合征(HRS)得到逆转,NA对改善HRS患者预后有积极的作用。
- 肝肾综合征 /
- 去甲肾上腺素 /
- 多巴胺
Abstract: Objective To investigate and analysis the effect of Noradrenaline and Dopamine on treating hepatorenal syndrome (HRS) .Methods 40 cases with hepatorenal syndrome were randomly divided into noradrenaline (NA) group and dopamine (DM) group, The kidney function and urine volume were observed.Results The level of serum creatinine and blood urea nitrogen decreased signicantly after treatment in NA group (P<0.05) , The volume of urine output increased significantly after treatment in DM group (P<0.05) .Conclusion NA group has a better treatment effect than DM group.Noradrenaline might reverse HRS and improve prognosis of patients with HRS.
- hepatorenal syndrome /
- Noradrenaline /
- Dopamine.

HTML全文

参考文献(5)

[1]阎明, 孟繁立.肝硬化肝肾综合征的治疗[J].中华肝脏病杂志, 2005, 13∶458.

[2]Gines P, Guevara M, Arroyo V, et al.Hepatorenal syndrome[J].Lancet, 2003, 362∶1819-1827.

[3]Arroyo V, Gines P, Gerbes A, et al.Definiti on and diagnosticcriteria of refractory ascites and hepatorenal syndrome in cirrhosis.International ascites clubs[J].Hepatology, 1996, 23∶164-173.

[4]Restuccia T, Guevara M, Gines P, et al.Effects of treatment ofhepatorenal syndrome before transplantation on posttransplatationoutcome∶A case-control study[J].J Hepatol, 2004, 40 (1) ∶140∶146.

[5]Moreau R.The growing evidence that renal function should be im-proved in patients with cirrhosis and hepatorenal syndrome beforeliver transplantation[J].J Hepatol, 2004, 40∶159-161.

施引文献

资源附件(0)

访问统计